Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Epstein

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Clinicoeconomics and Outcomes Research : CEOR|September 17, 2021
Payer Perspectives on Intravenous versus Subcutaneous Administration of DrugsRobert S Epstein
Health Affairs (Project Hope)|October 11, 2012
The hypothetical migraine drug comparative effectiveness study: a payer's recommendations for obtaining more useful resultsRobert S Epstein
Journal of Comparative Effectiveness Research|November 19, 2013
R&D transformation and value-based innovationRobert S Epstein
Mayo Clinic Proceedings|April 2, 2011
Medication adherence: hope for improvement?Robert S Epstein
Pharmacoeconomics|September 14, 2010
Comparative effectiveness research and personalized medicine: catalyzing or colliding?Robert S Epstein, J Russell Teagarden
Future Oncology (London, England)|October 12, 2021
Real-world use and outcomes of hypomethylating agent therapy in higher-risk myelodysplastic syndromes: why are we not achieving the promise of clinical trials?Amer M Zeidan, Tehseen Salimi, Robert S Epstein
Journal of Comparative Effectiveness Research|November 19, 2013
Integrating new approaches for clinical development: translational research and relative effectivenessJean-Pierre Lehner, Robert S Epstein, Tehseen Salimi
Expert Review of Anticancer Therapy|August 7, 2025
Oral decitabine and cedazuridine for the treatment of myelodysplastic syndromes: an integrated review of clinical, economic and patient-centered evidenceAmer M Zeidan, Ruizhi Zhao, Robert S Epstein, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Integrating scientific and real-world evidence within and beyond the drug development processRobert S Epstein, Jaan Sidorov, Jean-Pierre Lehner, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
A framework for pharmaceutical value-based innovationsTehseen Salimi, Jean-Pierre Lehner, Robert S Epstein, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Clinicoeconomics and Outcomes Research : CEOR|September 17, 2021
Payer Perspectives on Intravenous versus Subcutaneous Administration of DrugsRobert S Epstein
Health Affairs (Project Hope)|October 11, 2012
The hypothetical migraine drug comparative effectiveness study: a payer's recommendations for obtaining more useful resultsRobert S Epstein
Journal of Comparative Effectiveness Research|November 19, 2013
R&D transformation and value-based innovationRobert S Epstein
Mayo Clinic Proceedings|April 2, 2011
Medication adherence: hope for improvement?Robert S Epstein
Pharmacoeconomics|September 14, 2010
Comparative effectiveness research and personalized medicine: catalyzing or colliding?Robert S Epstein, J Russell Teagarden
Future Oncology (London, England)|October 12, 2021
Real-world use and outcomes of hypomethylating agent therapy in higher-risk myelodysplastic syndromes: why are we not achieving the promise of clinical trials?Amer M Zeidan, Tehseen Salimi, Robert S Epstein
Journal of Comparative Effectiveness Research|November 19, 2013
Integrating new approaches for clinical development: translational research and relative effectivenessJean-Pierre Lehner, Robert S Epstein, Tehseen Salimi
Expert Review of Anticancer Therapy|August 7, 2025
Oral decitabine and cedazuridine for the treatment of myelodysplastic syndromes: an integrated review of clinical, economic and patient-centered evidenceAmer M Zeidan, Ruizhi Zhao, Robert S Epstein, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Integrating scientific and real-world evidence within and beyond the drug development processRobert S Epstein, Jaan Sidorov, Jean-Pierre Lehner, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
A framework for pharmaceutical value-based innovationsTehseen Salimi, Jean-Pierre Lehner, Robert S Epstein, et al.
Pageof 5